Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

Method and diagnostic kit for diagnosing susceptibility of post-traumatic scar tissue formation

Popular

Description

Our partner, a Hungarian University has developed a new method and diagnostic kit for diagnosing susceptibility of post-traumatic scar tissue formation. The client is interested in finding producers and / or a product developer to acquire the patent rights through an in-licence agreement and also interested in potential distributors. 

 

 

The invention is a PCR-based method and a diagnostic kit for diagnosing post-traumatic scar tissue formulation with the TGF-ß1 gene-specific sequence. If the patient carries this gene's homozygotic wild type allele, then this patient is considered to be susceptible to post-traumatic scar tissue. 

The patenting process is currently underway in the US (Pub. No. US20100297648) and was granted in Hungary (Pub. No. HU0700313) for the PCR-based diagnostic method and diagnostic kit for diagnosing post-traumetic scar tissue formation.  

 Main advantages

 Early stage diagnostic of post-traumatic tracheal scar tissue;

  • Patient-friendly method;
  • Opportunity for prophylaxis;
  • Easy and simple way to diagnose accurately;
  • Economical to use.

 

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 661

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

A pharmaceutical company from Turkey, selling...
860 Views
Wuxi Griffin Pharmaceuticals Co. Ltd. is...
528 Views
A pharmaceutical company from Turkey, selling...
679 Views
Active substance formulated into Tivortin®  –...
769 Views
1. An entirely new combination. An original...
528 Views
I’m a representative of Parafarm (Penza,...
1491 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
1297 Views